Naphthalene diimide-naphthalimide dyads promote telomere damage by selectively targeting multimeric G-quadruplexes
Nucleic Acids Research · 2025
DOI: 10.1093/nar/gkaf301 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2025. Verfasst von Valentina Pirota und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Pavia, 27100 Pavia, Italy. Hauptthemen laut MEDLINE: G-Quadruplexes, Telomere, Imides, Naphthalenes. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: European Union, Fondazione Umberto Veronesi, National Center for Gene Therapy and Drugs.
Abstract (Originalsprache)
G-quadruplex (G4) nucleic acid ligands have attracted significant attention as putative anticancer agents for selectively stabilizing telomeric structures. In our pursuit of targeting the most biologically relevant telomeric structures, we have investigated a new class of naphthalene diimide (NDI)-based ligands designed to bind multimeric G4s. The NDI unit covalently linked with one 1,8-naphthalimide (NI) moiety, results in ligands able to fold into a sandwich-like conformation fitting into the binding pockets of telomeric multimeric G4s, thus optimizing binding complementarity. Varying the NDI decorations, we synthesized a small library of NDI-NI dyads and then examined their capability of stabilizing G4s by biophysical assays. Given the relevance of G4 stabilizing agents in fighting cancer, the most promising NDI-NIs were evaluated for their antitumoral activity on a panel of human cell lines originating from different tumor histotypes. Obtained results evidenced that three of the selected ligands promoted an accumulation of telomere-localized damage leading to a robust impairment of cell viability, regardless of homologous recombination status. These data, then confirmed in advanced 3D models, paved the way for the advancement of NDI-NIs as a new class of clinically relevant antitumoral agents. Finally, computational analyses gained deeper insight into their binding modality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of Pavia, 27100 Pavia, Italy.
- Translational Oncology Research Unit, IRCCS - Regina Elena National Cancer Institute, 00144 Rome, Italy.
- Department of Chemical Sciences, University of Naples Federico II, 80126 Naples, Italy.
- Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, 08028 Barcelona, Spain.
- Department of Biochemistry and Biomedicine, University of Barcelona, 08028 Barcelona, Spain.
ORCID-Profile: Valentina Pirota, Federica Battistini, Modesto Orozco, Mauro Freccero, Annamaria Biroccio, Daniela Montesarchio, Filippo Doria
Förderung
- European Union
- Fondazione Umberto Veronesi
- National Center for Gene Therapy and Drugs
- Fondazione AIRC
Zitieren
APA
Pirota, V., Iachettini, S., Platella, C., Zizza, P., Fracchioni, G., Di Vito, S., Carachino, A., Battistini, F., Orozco, M., Freccero, M., Biroccio, A., Montesarchio, D., & Doria, F. (2025). Naphthalene diimide-naphthalimide dyads promote telomere damage by selectively targeting multimeric G-quadruplexes. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf301
Vancouver
Pirota V, Iachettini S, Platella C, Zizza P, Fracchioni G, Di Vito S, et al. Naphthalene diimide-naphthalimide dyads promote telomere damage by selectively targeting multimeric G-quadruplexes. Nucleic Acids Research. 2025. doi:10.1093/nar/gkaf301
BibTeX
@article{Pirota2025,
author = {Pirota, Valentina and Iachettini, Sara and Platella, Chiara and Zizza, Pasquale and Fracchioni, Giorgia and Di Vito, Serena and Carachino, Alice and Battistini, Federica and Orozco, Modesto and Freccero, Mauro and Biroccio, Annamaria and Montesarchio, Daniela and Doria, Filippo},
title = {Naphthalene diimide-naphthalimide dyads promote telomere damage by selectively targeting multimeric G-quadruplexes},
journal = {Nucleic Acids Research},
year = {2025},
doi = {10.1093/nar/gkaf301}
}
EUVIMED